deramiocel
Asset
Allogeneic cardiosphere-derived cell therapy for Duchenne muscular dystrophy
- Stage
- Phase 3
- Modality
- Cell therapy
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Duchenne muscular dystrophy
Phase 3, globenewswire.com, 5 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.